Exelixis Inc (EXEL)
33.29
-0.39
(-1.16%)
USD |
NASDAQ |
Dec 20, 16:00
33.29
0.00 (0.00%)
After-Hours: 20:00
Exelixis Shareholders Equity (Quarterly): 2.275B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co Inc | 44.50B |
| ADMA Biologics Inc | 231.89M |
| Alnylam Pharmaceuticals Inc | 32.35M |
| Pfizer Inc | 92.29B |
| Sarepta Therapeutics Inc | 1.221B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.960B |
| Total Liabilities (Quarterly) | 684.86M |
| Current Ratio | 3.930 |